Internal Medicine, Medical Oncology · Jackson, MS
NPI
1639380207
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2969 Curran Dr N, Suite 200
Jackson, MS, 39216
Phone (601) 974-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$8.0M
387,564 services
Medicare patients, 2024
1,246
Average age 74
Drug cost, 2024
$7.3M
2,507 prescriptions
Company payments, 2025
$1,156
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicole D Cleveland was code J9299 (injection, nivolumab, 1 mg), 28,580 times for 23 patients. In total Nicole D Cleveland billed 387,564 services in 195 codes, and Medicare paid $8.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9299 Injection, nivolumab, 1 mg | Office | 28,580 | 23 | $24.54 | $701K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 28,160 | 26 | $0.06 | $1,582 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 25,800 | 32 | $44.59 | $1.2M |
| J0185 Injection, aprepitant, 1 mg | Office | 24,700 | 64 | $1.32 | $33K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 23,760 | 65 | $21.32 | $507K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 14,250 | 12 | $0.87 | $12K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 12,960 | 20 | $38.15 | $494K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 12,850 | 68 | $34.93 | $449K |
| J0897 Injection, denosumab, 1 mg | Office | 10,920 | 45 | $20.43 | $223K |
| J9264 Injection, paclitaxel protein-bound particles, 1 mg | Office | 10,600 | 16 | $8.85 | $94K |
| J9036 Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg | Office | 10,375 | 12 | $5.50 | $57K |
| J9311 Injection, rituximab 10 mg and hyaluronidase | Office | 8,460 | 15 | $25.63 | $217K |
| J9022 Injection, atezolizumab, 10 mg | Office | 5,400 | 11 | $66.38 | $358K |
| J9047 Injection, carfilzomib, 1 mg | Office | 5,210 | 14 | $37.87 | $197K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 5,130 | 121 | $0.09 | $447 |
By year: 2022 $4.7M for 347,141 services; 2023 $4.7M for 278,409 services; 2024 $8.0M for 387,564 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,657 | 837 | $7.35 | $20K |
| 80053 Clinical Chemistry | 2,346 | 813 | $10.07 | $24K |
| 36415 Venipuncture Blood Collection | 2,065 | 803 | $8.44 | $17K |
| 82728 Clinical Chemistry | 732 | 437 | $12.99 | $9,512 |
| 83550 Clinical Chemistry | 649 | 403 | $8.35 | $5,419 |
| 83540 Clinical Chemistry | 649 | 403 | $6.18 | $4,009 |
| 82784 Immunoassay | 546 | 90 | $8.82 | $4,814 |
| 86300 Immunoassay | 459 | 211 | $20.01 | $9,187 |
| 83521 Immunoassay | 318 | 76 | $16.85 | $5,359 |
| 84443 Clinical Chemistry | 311 | 97 | $16.46 | $5,119 |
Medicare prescription drug claims, 2024
In 2024, the drug Nicole D Cleveland prescribed most often to Medicare patients was Letrozole, with 217 prescriptions and refills. In total Nicole D Cleveland wrote 2,507 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 217 | 444 | 59 | $2,958 |
| Tamoxifen Citrate Generic | 141 | 295 | 44 | $3,290 |
| Prednisone Generic | 110 | 118 | 57 | $336 |
| Eliquis Apixaban | 92 | 124 | 17 | $71K |
| Lenalidomide Generic | 82 | 82 | Under 11 | $1.2M |
| Acyclovir Generic | 81 | 96 | 20 | $813 |
| Dexamethasone Generic | 73 | 114 | 24 | $1,223 |
| Ondansetron Odt Ondansetron | 72 | 74 | 49 | $1,140 |
| Gabapentin Generic | 69 | 87 | 22 | $439 |
| Raloxifene Hcl Generic | 57 | 112 | 15 | $1,519 |
| Calquence Acalabrutinib Maleate | 55 | 55 | Under 11 | $719K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 54 | 54 | 37 | $1,304 |
| Ondansetron Hcl Generic | 54 | 55 | 32 | $703 |
| Imbruvica Ibrutinib | 51 | 51 | Under 11 | $770K |
| Tramadol Hcl Generic | 47 | 48 | 19 | $289 |
Brand drugs: 627 claims; generic drugs: 1,880 claims; opioid claims: 141.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicole D Cleveland $1,156 ($1,156 in general payments such as food, travel and fees) from 24 companies. The largest payer was Celgene Corporation with $156.
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation BMY | 7 | $156 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $144 |
| Janssen Biotech, Inc. JNJ | 2 | $124 |
| TerSera Therapeutics LLC | 3 | $99.13 |
| Daiichi Sankyo Inc. 4568.T | 4 | $82.03 |
| Astellas Pharma US Inc 4503.T | 3 | $70.96 |
| Abbvie Inc. ABBV | 3 | $59.96 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $54.6 |
| Recordati_rare_diseases_inc. | 2 | $40.72 |
| BeOne Medicines USA, Inc. ONC | 2 | $36.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.